MARKET

AKYA

AKYA

Akoya Biosciences, Inc.
NASDAQ
3.030
-0.070
-2.26%
Closed 16:20 10/09 EDT
OPEN
3.080
PREV CLOSE
3.100
HIGH
3.140
LOW
3.000
VOLUME
107.43K
TURNOVER
0
52 WEEK HIGH
6.31
52 WEEK LOW
1.880
MARKET CAP
149.98M
P/E (TTM)
-2.4743
1D
5D
1M
3M
1Y
5Y
1D
Akoya Biosciences, Inc. (NASDAQ:AKYA) Stock Rockets 36% But Many Are Still Ignoring The Company
Simply Wall St · 2d ago
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 3d ago
Akoya’s PhenoCycler, PhenoImager platforms selected by MANIFEST Consortium
TipRanks · 3d ago
AKOYA’S LEADING SPATIAL PROTEOMICS PLATFORMS SELECTED FOR USE BY GROUND-BREAKING UK-BASED MANIFEST CONSORTIUM TO REVOLUTIONIZE CANCER IMMUNOTHERAPY
Reuters · 3d ago
Weekly Report: what happened at AKYA last week (0930-1004)?
Weekly Report · 3d ago
Akoya Biosciences chairman Robert Shepler to leave role, Scott Mendel to succeed
TipRanks · 5d ago
Akoya Biosciences Announces Scott Mendel Appointed As Chairman Of The Board Of Directors, Effective October 2, 2024
Benzinga · 10/03 20:02
AKOYA BIOSCIENCES INC - MENDEL SUCCEEDS ROBERT SHEPLER
Reuters · 10/03 20:00
More
About AKYA
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).

Webull offers Akoya Biosciences Inc stock information, including NASDAQ: AKYA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AKYA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AKYA stock methods without spending real money on the virtual paper trading platform.